Education
About Us
Working with TipRanks
Follow Us
Douglas A Treco Insider Profile
4 Followers
Douglas A Treco, President & CEO, Director at Ra Pharmaceuticals, holds 0.00 shares in Ra Pharmaceuticals (Ticker: RARX), holds ― shares in Crispr Therapeutics AG (Ticker: CRSP), holds 22.38K shares in Inozyme Pharma (Ticker: INZY).
Douglas A Treco Ra Pharmaceuticals (RARX)President & CEO, Director
Ra Pharmaceuticals (RARX)
President & CEO, Director
Not Ranked
Douglas A Treco has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Douglas A Treco holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Douglas A Treco
Douglas A Treco's Trading History
Ra Pharmaceuticals
Apr 03, 2020
―
Uninformative Sell
11.27M
$0.00
Crispr Therapeutics AG
―
Director
―
―
Inozyme Pharma
Oct 03, 2024
CEO, Director
Uninformative Buy
7.61K
$25.73K
List of latest transactions for each holding click on a transaction to see Douglas A Treco's performance on stock
You May Also Like
Douglas A Treco insider profile FAQ
What is the percentage of profitable transactions made by Douglas A Treco?
The percentage of profitable transactions made by Douglas A Treco is ―.
What is the average return per transaction made by Douglas A Treco?
The average return per transaction made by Douglas A Treco is ―.
What stocks does Douglas A Treco hold?
Douglas A Treco holds: RARX, CRSP, INZY stocks.
What was Douglas A Treco’s latest transaction?
Douglas A Treco latest transaction was an Uninformative Sell of $11.27M.
What was Douglas A Treco's most profitable transaction?
Douglas A Treco’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Douglas A Treco's role in Ra Pharmaceuticals?
Douglas A Treco's role in Ra Pharmaceuticals is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.